Asian Fund for Cancer Research/LinkedIn
Jul 16, 2025, 14:38
Bringing Breakthrough Hope to Patients With Glioblastoma – Asian Fund for Cancer Research
Asian Fund for Cancer Research shared a post on LinkedIn:
“Glioblastoma (GBM) is a highly aggressive form of brain cancer that can hit patients and families hard.
AFCR is committed to promoting patient-centred solutions to find more effective treatments. We are also actively involved in leading projects such as:
- GBM AGILE – The world’s first GBM adaptive clinical trial platform
- PIONEER Oncology – Accelerating Brain Cancer Drug Innovation in Asia
Please join us in bringing breakthrough hope to patients.”
You can also read:
Glioblastoma Awareness Day 2025: Uniting for Progress and Hope
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 16, 2025, 17:55
Jul 16, 2025, 17:38
Jul 16, 2025, 17:37
Jul 16, 2025, 17:04
Jul 16, 2025, 16:51
Jul 16, 2025, 16:34
Jul 16, 2025, 16:18
Jul 16, 2025, 16:06